Literature DB >> 25195101

Diagnostic performance of cardiac Troponin I for early rule-in and rule-out of acute myocardial infarction: Results of a prospective multicenter trial.

Alan B Storrow1, Robert H Christenson2, Richard M Nowak3, Deborah B Diercks4, Adam J Singer5, Alan H B Wu6, Erik Kulstad7, Frank LoVecchio8, Christian Fromm9, Gary Headden10, Tracie Potis11, Christopher J Hogan12, Jon W Schrock13, Daniel P Zelinski14, Marna R Greenberg15, James C Ritchie16, Janna S Chamberlin17, Kurtis R Bray17, Daniel W Rhodes17, Deirdre Trainor17, Dawn Holmes17, Paula C Southwick17.   

Abstract

OBJECTIVES: To compare emergency department TnI serial sampling intervals, determine optimal diagnostic thresholds, and report representative diagnostic performance characteristics for early rule-in and rule-out of MI.
METHODS: We prospectively measured TnI (AccuTnI+3™, Beckman Coulter) at serial time intervals in 1929 subjects with chest pain or equivalent ischemic symptoms suggestive of acute coronary syndromes at 14 medical centers. Diagnosis was adjudicated by an independent central committee.
RESULTS: TnI ≥0.03ng/mL provided 96.0% sensitivity and 89.4% specificity at 1-3h after admission, and 94.9% sensitivity and 86.7% specificity at 3-6h. NPV (rule-out, non-MI) was 99.5% at 1-3h, and 99.0% at 3-6h when TnI is <0.03ng/mL. NPV was 99.1% when TnI is <0.03ng/mL and time of symptom onset is ≥8h. Approximately 50-58% (PPV) of patients with TnI ≥0.03ng/mL were diagnosed with MI, depending upon time from onset or admission; PPVs emphasize the importance of serial samples and delta TnI (rising or falling pattern) when low cutoffs are used. Nevertheless, even a single elevated TnI value increased the risk of MI. As TnI values rose, the probability of MI increased. Values ≥0.20ng/mL were associated with nearly 90% probability of MI.
CONCLUSIONS: We report a large multicenter prospective adjudicated trial assessing troponin for early rule-in and rule-out using the Universal Definition of MI and conducted in primary care hospital-associated emergency departments. Our study demonstrates high diagnostic accuracy at early observation times, and reinforces consensus recommendations for sampling on admission and 3h later, repeated at 6h when clinical suspicion remains high.
Copyright © 2014 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute coronary syndromes; Biomarkers; Chest pain; Diagnosis; Emergency medicine; Myocardial infarction; Troponin

Mesh:

Substances:

Year:  2014        PMID: 25195101     DOI: 10.1016/j.clinbiochem.2014.08.018

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  7 in total

1.  Performance of the 2-hour accelerated diagnostic protocol within the American College of Radiology Imaging Network PA 4005 cohort.

Authors:  Simon A Mahler; Chadwick D Miller; Harold I Litt; Constantine A Gatsonis; Bradley S Snyder; Judd E Hollander
Journal:  Acad Emerg Med       Date:  2015-03-24       Impact factor: 3.451

2.  Validation of the No Objective Testing Rule and Comparison to the HEART Pathway.

Authors:  Jason P Stopyra; Chadwick D Miller; Brian C Hiestand; Cedric W Lefebvre; Bret A Nicks; David M Cline; Kim L Askew; Robert F Riley; Gregory B Russell; James W Hoekstra; Simon A Mahler
Journal:  Acad Emerg Med       Date:  2017-08-08       Impact factor: 3.451

3.  Elevated Admission Cardiac Troponin I Predicts Adverse Outcomes of Acute Type B Aortic Dissection after Endovascular Treatment.

Authors:  Kaiwen Zhao; Hongqiao Zhu; Lei Zhang; Junjun Liu; Yifei Pei; Jian Zhou; Zaiping Jing
Journal:  Front Surg       Date:  2022-06-07

4.  Comparison of accelerated diagnostic pathways for acute chest pain risk stratification.

Authors:  Jason Stopyra; Anna Catherine Snavely; Brian Hiestand; Brian J Wells; Kristin Macfarlane Lenoir; David Herrington; Nella Hendley; Nicklaus P Ashburn; Chadwick D Miller; Simon A Mahler
Journal:  Heart       Date:  2020-04-08       Impact factor: 5.994

5.  Performance of the EDACS-accelerated Diagnostic Pathway in a Cohort of US Patients with Acute Chest Pain.

Authors:  Jason P Stopyra; Chadwick D Miller; Brian C Hiestand; Cedric W Lefebvre; Bret A Nicks; David M Cline; Kim L Askew; Robert F Riley; Gregory B Russell; James W Hoekstra; Simon A Mahler
Journal:  Crit Pathw Cardiol       Date:  2015-12

6.  Graded Coronary Risk Stratification for Emergency Department Patients With Chest Pain: A Controlled Cohort Study.

Authors:  Dustin G Mark; Jie Huang; Dustin W Ballard; Mamata V Kene; Dana R Sax; Uli K Chettipally; James S Lin; Sean C Bouvet; Dale M Cotton; Megan L Anderson; Ian D McLachlan; Laura E Simon; Judy Shan; Adina S Rauchwerger; David R Vinson; Mary E Reed
Journal:  J Am Heart Assoc       Date:  2021-11-06       Impact factor: 5.501

7.  Myocardial Infarction Can Be Safely Excluded by High-sensitivity Troponin I Testing 3 Hours After Emergency Department Presentation.

Authors:  W Frank Peacock; Robert Christenson; Deborah B Diercks; Christian Fromm; Gary F Headden; Christopher J Hogan; Erik B Kulstad; Frank LoVecchio; Richard M Nowak; Jon W Schrock; Adam J Singer; Alan B Storrow; Joely Straseski; Alan H B Wu; Daniel P Zelinski
Journal:  Acad Emerg Med       Date:  2020-03-27       Impact factor: 3.451

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.